UBS Starts Kenvue Inc (KVUE) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- Trump threatens to bomb Oman over Iran stance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
Analysts mostly cautious on Kenvue (KVUE) given JNJ's intentions to sell more shares
May 30, 2023 7:49 AM EDTWall Street analysts launched research coverage on Kenvue (NYSE: KVUE) after the company made its trading debut earlier this month.
Kenvue sold 172.8 million shares in the initial public offering (IPO), raising $3.8 billion and valuing the healthcare company at about $41B. JNJ initially planned to sell 151M shares but changed plans due to a higher-than-expected interest. The pharma giant owns an 89.6% stake in... More
